Transdermal formulation containing...

Details Transdermal formulation containing... Transdermal formulation containing...

A - Human Necessities

61

M

167/231

A61M 37/00 (2006.01) A61K 9/70 (2006.01) A61K 31/44 (2006.01) A61K 47/00 (2006.01) A61K 47/06 (2006.01) A61K 47/10 (2006.01)

Patent

CA 1318598

Abstract of the Disclosure: A transdermal absorptive drug formulation containing 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine as active ingredient effective for bronchial asthma and cerebrovascular disorder is provided. The formulation affords excellent sustained releasing and long acting characteristics with substantially reduced side-effects such as nausea and vomitting.

585088

Affiliated with

Also associated with

Rating

Transdermal formulation containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal formulation containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal formulation containing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1273490